# Safety and Efficacy of CJ-50300 in Healthy Volunteers

> **NCT00607243** · PHASE2,PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 123 (actual)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** smallpox vaccine CJ-50300

## Key facts

- **NCT ID:** NCT00607243
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-12
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2013-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607243, "Safety and Efficacy of CJ-50300 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00607243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*